Kulicke & Soffa Industries Inc
KLIC Nasdaq Semiconductors & Related Devices Financials FY2016βFY2025
What Kulicke & Soffa Industries Inc does
No business description yet.
- Legal name
- KULICKE & SOFFA INDUSTRIES INC
- Fiscal year ends
- October 4, 2025
- Latest annual report
- 10-K Β· Nov 20, 2025
- Accession Β· CIK
- 0000056978-25-000081
0000056978
Revenue and margins
Kulicke & Soffa Industries Inc had $654M of revenue in fiscal 2025, down 7.4% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew β43.5% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $96.4M in fiscal 2025, 14.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Kulicke & Soffa Industries Inc returned $97.1M to shareholders in fiscal 2025, 101% of free cash flow. The diluted share count fell 4.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Kulicke & Soffa Industries Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $740M | $776M | $759M | $577M | $511M |
| Interest coverage | 1,892.0x | 2,260.0x | 277.7x | β1,039.3x | β24.1x |
| Current ratio | 3.8x | 5.4x | 6.5x | 5.4x | 4.8x |
| Quick ratio | 3.4x | 4.6x | 5.4x | 4.4x | 3.9x |
| Total assets | $1.6B | $1.6B | $1.5B | $1.2B | $1.1B |
| Total liabilities | $506M | $394M | $325M | $296M | $283M |
| Shareholders' equity | $1.1B | $1.2B | $1.2B | $944M | $821M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 6 / 8 | 6 / 8 | 5 / 8 | 8 / 8 | 4 / 8 | 6 / 8 | 5 / 8 | 4 / 8 | 7 / 8 |
| Accruals ratio | β2.0% | β0.9% | β5.7% | β4.8% | β3.9% | 5.1% | 2.7% | β7.5% | β7.3% | β9.7% |
| Altman Z'' | 10.80 | 10.34 | 10.16 | 8.90 | 9.33 | 10.03 | 12.40 | 11.32 | 10.40 | 10.81 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $627M | $809M | $889M | $540M | $623M | $1.5B | $1.5B | $742M | $706M | $654M |
| Gross profit | $281M | $382M | $409M | $255M | $298M | $697M | $748M | $359M | $269M | $278M |
| Research and development | $92.4M | $100M | $120M | $116M | $123M | $137M | $137M | $145M | $151M | $150M |
| Operating income | $54.0M | $113M | $167M | $21.6M | $58.5M | $412M | $470M | $39.4M | β$92.5M | β$3.2M |
| Interest expense | $1.1M | $1.1M | $1.1M | $2.1M | $1.7M | $0.2M | $0.2M | $0.1M | $0.1M | $0.1M |
| Pretax income | $56.2M | $119M | $178M | $34.7M | $64.3M | $415M | $477M | $72.2M | β$58.4M | $20.5M |
| Income tax | $7.7M | β$7.4M | $121M | $22.9M | $12.0M | $47.3M | $43.4M | $15.1M | $10.7M | $20.3M |
| Net income | $48.5M | $126M | $56.7M | $11.7M | $52.3M | $367M | $434M | $57.1M | β$69.0M | $0.2M |
| Net income to common | $47.1M | β | β | β | β | β | β | β | β | β |
| Diluted EPS | $0.68 | $1.75 | $0.80 | $0.18 | $0.83 | $5.78 | $7.09 | $0.99 | β$1.24 | $0.00 |
| Diluted shares | 0.07B | 0.07B | 0.07B | 0.07B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $68.4M | $136M | $123M | $66.0M | $94.4M | $300M | $390M | $173M | $31.0M | $114M |
| Capital expenditure | $6.2M | $25.6M | $20.5M | $11.7M | $11.7M | $22.8M | $23.0M | $44.4M | $16.1M | $17.2M |
| Free cash flow | $62.2M | $111M | $103M | $54.2M | $82.7M | $277M | $367M | $129M | $14.9M | $96.4M |
| Depreciation and amortization | $16.2M | $16.3M | $19.0M | $20.3M | $19.7M | $19.8M | $21.3M | $28.9M | $24.7M | $18.0M |
| Stock-based compensation | $5.7M | $11.7M | $11.7M | $14.3M | $15.0M | $15.5M | $19.0M | $22.7M | $26.9M | $28.5M |
| Acquisitions | $0.0M | $27.1M | $0.0M | $0.0M | $0.0M | $26.3M | $0.0M | $36.9M | $0.0M | β |
| Share buybacks | $14.6M | $18.2M | $90.3M | $99.9M | $54.5M | $10.4M | $281M | $69.2M | $151M | $97.1M |
| Dividends paid | $0.0M | $0.0M | $8.2M | $31.6M | $30.2M | $33.5M | $39.4M | $42.0M | $44.2M | β |
| Dividends and buybacks | $14.6M | $18.2M | $98.5M | $131M | $84.8M | $43.9M | $321M | $111M | $195M | $97.1M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $548M | $608M | $614M | $593M | $530M | $740M | $776M | $759M | $577M | $511M |
| Current assets | $781M | $953M | $987M | $894M | $860M | $1.4B | $1.3B | $1.2B | $995M | $902M |
| Current liabilities | $126M | $193M | $174M | $175M | $158M | $352M | $249M | $182M | $184M | $188M |
| Inventory | $87.3M | $122M | $115M | $89.3M | $112M | $167M | $185M | $217M | $178M | $160M |
| Property and equipment, net | $50.3M | $67.8M | $76.1M | $72.4M | $59.1M | $68.0M | $80.9M | $110M | $64.8M | $59.0M |
| Goodwill | $81.3M | $56.3M | $56.6M | $55.7M | $56.7M | $72.9M | $68.1M | $88.7M | $89.7M | $69.5M |
| Intangible assets | $50.8M | $62.3M | $52.9M | $42.7M | $38.0M | $42.8M | $31.9M | $29.4M | $25.2M | $5.6M |
| Total assets | $982M | $1.2B | $1.2B | $1.1B | $1.1B | $1.6B | $1.6B | $1.5B | $1.2B | $1.1B |
| Total liabilities | $183M | $251M | $306M | $311M | $297M | $506M | $394M | $325M | $296M | $283M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $800M | $920M | $880M | $769M | $758M | $1.1B | $1.2B | $1.2B | $944M | $821M |
| Margins | ||||||||||
| Gross margin | 44.8% | 47.2% | 46.1% | 47.1% | 47.8% | 45.9% | 49.8% | 48.3% | 38.1% | 42.5% |
| Operating margin | 8.6% | 14.0% | 18.7% | 4.0% | 9.4% | 27.2% | 31.3% | 5.3% | β13.1% | β0.5% |
| EBITDA margin | 11.2% | 16.0% | 20.9% | 7.8% | 12.6% | 28.5% | 32.7% | 9.2% | β9.6% | 2.3% |
| Net margin | 7.7% | 15.6% | 6.4% | 2.2% | 8.4% | 24.2% | 28.8% | 7.7% | β9.8% | 0.0% |
| FCF margin | 9.9% | 13.7% | 11.6% | 10.0% | 13.3% | 18.3% | 24.4% | 17.4% | 2.1% | 14.7% |
| Returns | ||||||||||
| Return on capital employed | 6.3% | 11.6% | 16.5% | 2.4% | 6.5% | 33.0% | 35.1% | 3.0% | β8.8% | β0.4% |
| Return on equity | 6.1% | 14.7% | 6.3% | 1.4% | 6.8% | 39.6% | 37.9% | 4.8% | β6.5% | 0.0% |
| Return on assets | 4.9% | 11.7% | 4.8% | 1.0% | 4.9% | 27.6% | 27.2% | 3.7% | β5.0% | 0.0% |
| Return on tangible equity | 7.1% | 15.7% | 7.4% | 1.7% | 7.9% | 37.5% | 39.6% | 5.4% | β8.3% | 0.0% |
| Growth | ||||||||||
| Revenue growth | β | 29.0% | 9.9% | β39.3% | 15.4% | 143.5% | β0.9% | β50.6% | β4.9% | β7.4% |
| Net income growth | β | 160.2% | β55.1% | β79.4% | 348.8% | 602.0% | 18.1% | β86.8% | β220.7% | β |
| EPS growth | β | 157.4% | β54.3% | β77.5% | 361.1% | 596.4% | 22.7% | β86.0% | β225.3% | β |
| FCF growth | β | 78.0% | β7.0% | β47.4% | 52.5% | 235.3% | 32.4% | β64.9% | β88.5% | 547.2% |
| Share count change | β | 1.7% | β2.3% | β6.3% | β3.9% | 0.2% | β3.7% | β5.9% | β3.4% | β4.4% |
| Financial health | ||||||||||
| Interest coverage | 48.7x | 106.8x | 158.1x | 10.5x | 34.1x | 1,892.0x | 2,260.0x | 277.7x | β1,039.3x | β24.1x |
| Current ratio | 6.2x | 4.9x | 5.7x | 5.1x | 5.4x | 3.8x | 5.4x | 6.5x | 5.4x | 4.8x |
| Quick ratio | 5.5x | 4.3x | 5.0x | 4.6x | 4.7x | 3.4x | 4.6x | 5.4x | 4.4x | 3.9x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.0% | 3.2% | 2.3% | 2.2% | 1.9% | 1.5% | 1.5% | 6.0% | 2.3% | 2.6% |
| Stock comp / revenue | 0.9% | 1.4% | 1.3% | 2.7% | 2.4% | 1.0% | 1.3% | 3.1% | 3.8% | 4.4% |
| Payouts / FCF | 23.4% | 16.4% | 95.6% | 242.4% | 102.5% | 15.8% | 87.3% | 86.2% | 1,309.4% | 100.8% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 6.0 | 6.0 | 5.0 | 8.0 | 4.0 | 6.0 | 5.0 | 4.0 | 7.0 |
| Altman Z'' | 10.8 | 10.3 | 10.2 | 8.9 | 9.3 | 10.0 | 12.4 | 11.3 | 10.4 | 10.8 |
| Accruals ratio | β2.0% | β0.9% | β5.7% | β4.8% | β3.9% | 5.1% | 2.7% | β7.5% | β7.3% | β9.7% |
Source: SEC EDGAR XBRL filings (CIK 0000056978). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.